Nephrotic syndrome complicated with portal, splenic, and superior Nephrotic syndrome complicated with portal, splenic, and superior

´ëÇѽÅÀåÇÐȸÁö 2014³â 33±Ç 3È£ p.161 ~ p.164

¹ÚºÀ¼ö(Park Bong-Soo) - Inje University College of Medicine Haeundae Paik Hospital Department of Internal Medicine
¹Ú½ÃÇü(Park Si-Hyung) - Inje University College of Medicine Haeundae Paik Hospital Department of Internal Medicine
Áø±Ôº¹(Jin Kyu-Bok) - Inje University College of Medicine Haeundae Paik Hospital Department of Internal Medicine
Ãֱ⺹(Choi Gi-Bok) - Inje University College of Medicine Haeundae Paik Hospital Department of Radiology
¹Ú°­¹Î(Park Kang-Min) - Inje University College of Medicine Haeundae Paik Hospital Department of Neurology
Á¶°æ¹Î(Jo Kyeong-Min) - Inje University College of Medicine Haeundae Paik Hospital Department of Internal Medicine
±è¾ç¿í(Kim Yang-Wook) - Inje University College of Medicine Haeundae Paik Hospital Department of Internal Medicine

Abstract

Thromboembolism is a major complication of nephrotic syndrome. Renal vein thrombosis and deep vein thrombosis are relatively common, especially in membranous nephropathy. However, the incidence of portal vein and superior mesenteric vein (SMV) thrombosis in patients with nephrotic syndrome is very rare. To date, several cases of portal vein thrombosis treated by anticoagulation therapy, not by thrombolytic therapy, have been reported as a complication of nephrotic syndrome. Here, we report a case of portal, splenic, and SMV thrombosis in a patient with a relapsed steroid dependent minimal change disease who was treated successfully with anticoagulation and thrombolytic therapy using urokinase. Radiologic ?ndings and his clinical conditions gradually improved. Six months later, a complete remission of the nephrotic syndrome was observed and the follow-up computed tomography scan showed the disappearance of all portal vein, splenic vein, and SMV thrombi.

Å°¿öµå

Complications, Nephrotic syndrome, Thrombolytic therapy, Venous thrombosis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå